Gene Screening and Result Analysis of 2 376 Cases of Thalassemia
-
摘要:
目的 了解于昆明医科大学第一附属医院就诊的地中海贫血(简称“地贫”)基因筛查者地贫基因阳性率和基因突变类型及分布特征。 方法 回顾性分析2017年4月1日至2018年12月31日于昆明医科大学第一附属医院就诊的地贫基因筛查者2376例,对地贫基因进行统计分析。 结果 (1)2 376例地贫基因筛查中检出地贫基因阳性样本817例,阳性率为34.39%;其中检出α地贫基因阳性样本392例,占总阳性样本的47.98%;β地贫基因阳性样本398例,占总阳性样本的48.71%;αβ复合型地贫基因阳性27例,占总阳性样本的3.30%;(2)392例α地贫基因阳性样本中以αα/--SEA、αα/-α3.7、αα/ααCS、αα/-α4.2和-α3.7/--SEA基因型为主,分别占α地贫的50.51%、32.91%、4.34%、3.57%和2.55%;398例β地贫基因阳性样本中以CD26、CD41-42、CD17、IVS II-654、nt28基因型为主,分别占β地贫的25.38%、23.37%、20.60%、20.60%和3.27%。 结论 云南地区地贫基因携带率仍较高,其中β地贫中CD26最多,与国内其它省市人群存在差异。 Abstract:Objective To investigate the positive rate, gene mutation type and distribution characteristics of thalassemia gene screening patients in the First Affiliated Hospital of Kunming Medical University. Methods A retrospective analysis was made on 2376 cases of thalassemia gene screening patients in the First Affiliated Hospital of Kunming Medical University from April 1, 2017 to December 31, 2018. The parameters of thalassemia gene and blood cell analysis (Hb, MCV, MCH, RDW) were statistically analyzed. Results (1) Among 2376 cases of thalassemia gene screening, 817 were positive for thalassemia gene, the positive rate was 34.39%, of which 392 cases were positive for α thalassemia gene, accounting for 47.98% of the total positive samples; 398 were positive samples of βthalassemia gene, accounting for 48.71% of the total positive samples; 27 cases were αβcompound thalassemia gene positive samples, accounting for 3.30% of the total positive samples. (2) 392 positive samples of αthalassemia gene were αα/--SEA、αα/-α3.7、αα/ααCS、αα/-α4.2 and -α3.7/--SEA genotypes, accounting for 50.51%, 32.91%, 4.34%, 3.57% and 2.55%, respectively; CD26, CD41-42, CD17, IVS II654, nt28 genotypes were the main positive samples of β thalassemia gene, accounting for 25.38%, 23.37%, 20.60%, 20.60% and 3.27% of thalassemia gene. Conclusion The incidence rate of thalassemia in Yunnan is still high, of which CD26 is the largest in beta thalassemia, which is totally different from that in other provinces and cities in China. -
Key words:
- Thalassemia /
- Gene mutation type /
- Screening
-
表 1 2376例样本地贫基因分布情况(%)
Table 1. Distribution of thalassemia gene in 2376 samples(%)
组别 n 总例数占比 基因阳性占比 α地贫基因 392 16.50 47.98 β地贫基因 398 16.75 48.71 αβ地贫基因 27 1.14 3.30 地贫基因阴性 1559 65.61 − 合计 2376 100.00 100.00 表 2 α地贫基因突变类型及其构成比(%)
Table 2. Mutation types and constituent ratios of α-thalassemia gene(%)
基因突变类型 n 占总例数百分比 占α百分比 αα/--SEA 198 24.24 50.51 αα/-α3.7 129 15.79 32.91 αα/ααCS 17 2.08 4.34 αα/-α4.2 14 1.71 3.57 -α3.7/--SEA 10 1.22 2.55 ααCS/-α4.2 1 0.12 0.26 -α3.7/-α3.7 2 0.24 0.51 -α4.2/-α3.7 1 0.12 0.26 αα/-αTCS 1 0.12 0.26 αα/ααQS 4 0.49 1.02 αα/ααWS 4 0.49 1.02 ααCS/--SEA 7 0.86 1.79 ααCS/ααCS 1 0.12 0.26 ααQS/--SEA 1 0.12 0.26 ααQS/-α3.7 1 0.12 0.26 ααWS/--SEA 1 0.12 0.26 合计 392 47.98 100.00 表 3 β地贫基因突变类型及其构成比(%)
Table 3. Mutation types and constituent ratios of β-thalassemia gene(%)
基因突变类型 n 占总例数百分比 占β百分比 CD26 101 12.36 25.38 CD41-42 93 11.38 23.37 CD17 82 10.04 20.60 IVS II-654 82 10.04 20.60 nt28 13 1.59 3.27 CD26及CD27 2 0.24 0.50 CD26及CD41-42 2 0.24 0.50 CD26/CD26及IVS II-654 1 0.12 0.25 CD37 3 0.37 0.75 CD71-72 8 0.98 2.01 IVS I-1 3 0.37 0.75 IVS II-5 1 0.12 0.25 nt29 4 0.49 1.01 nt73 3 0.37 0.75 合计 398 48.71 100.00 表 4 αβ地贫基因突变类型及其构成比(%)
Table 4. Mutation types and constituent ratios of α-β thalassemia gene(%)
基因突变
类型n 占总例数
百分比占αβ
百分比CD14-15及αα/-α3.7 1 0.12 3.70 CD17及αα/-α3.7 4 0.49 14.81 CD17及αα/ααCS 1 0.12 3.70 CD26及αα/--SEA 2 0.24 7.41 CD26及αα/-α3.7 4 0.49 14.81 CD26及ααQS/--SEA 1 0.12 3.70 CD26及CD41-42及αα/-α3.7 1 0.12 3.70 nt28及αα/-α3.7 1 0.12 3.70 CD37及αα/--SEA 1 0.12 3.70 CD41-42及αα/--SEA 3 0.37 11.11 CD41-42及αα/-α3.7 1 0.12 3.70 CD41-42及αα/ααQS 1 0.12 3.70 IVS II-654及αα/--SEA 2 0.24 7.41 IVS II-654及αα/-α3.7 2 0.24 7.41 IVS II-654及αα/-α4.2 1 0.12 3.70 IVS II-654及αα/ααQS 1 0.12 3.70 合计 27 3.30 100.00 -
[1] 张小庄, 冯占春, 叶宁. 地中海贫血的预防控制[M]. 北京: 人民卫生出版社, 2014: 1-2. [2] 刘兴梅, 李贵芳, 吴娴, 等. 贵州165例α-地中海贫血基因突变类型初步分析[J].重庆医学,2015,44(17):2146-2418. [3] 付月, 刘文君. 地中海贫血实验室诊断研究进展[J].中国实验血液学杂志,2018,26(2):631-636. [4] Huang SW, Xu Y, Liu XM, et a1. The prevalence and spectrum of α-thalassemia in Guizhou Province of South China[J]. Hemoglobin,2015,39(4):260-263. [5] Yu X, Yang LY, Yang H T, et a1. Molecular epidemiological investigation of thalassemia in the Chengdu Region, Sichuan Province, Southwest China[J]. Hemoglobin,2015,39(6):393-397. [6] 林慧, 段金良. 广西不孕症妇女α和β地中海贫血的基因鉴定[J].中国优生与遗传杂志,2016,24(1):47-48. [7] 张玲, 韩坤, 胡朝晖, 等. 广州地区528例珠蛋白生成障碍性贫血患者的ABO血型分布[J].检验医学与临床,2016,13(2):228-229. doi: 10.3969/j.issn.1672-9455.2016.02.030 [8] 林金瑞, 李介华, 黄振勇, 等. 清远地区CD41-42 β地中海贫血人群基因型组合特点及红细胞参数特点分析[J].广东医学,2015,36(3):410-413. [9] 姜碧, 姚倩瑜, 韦思似, 等. 东莞地区孕前优生健康检查夫妇地中海贫血结果分析[J].中国妇幼保健,2016,31(7):1475-1477. [10] 姜碧, 钟鸣, 韦思似, 等. 东莞地区育龄人群α地中海贫血分子流行病学调查[J].中国优生与遗传杂志,2015,23(7):22-23. [11] 陈淑芬, 赡淑莉, 宋春林, 等. 佛山地区非缺失型α地中海贫血基因突变分析[J].中国优生与遗传杂志,2015,23(3):17-22. [12] 余夏, 石明芳, 王双杰, 等. 91例同型地中海贫血基因携带者产前基因检测结果分析[J].检验医学,2019,34(3):240-243. doi: 10.3969/j.issn.1673-8640.2019.03.011 [13] 陈育华, 周碧云, 梁斯锶, 等. 1071例地中海贫血基因筛查结果分析[J].中国当代医药,2017,24(12):159-162. [14] 田文芳, 唐喜军. 广东省珠海地区α-和β-地中海贫血基因突变类型研究[J].检验医学与临床,2011,8(12):1487-1488. doi: 10.3969/j.issn.1672-9455.2011.12.038 [15] 李猛, 项松鹤, 丁一, 等. 中国海南省三亚地区地中海贫血基因类型分析[J].中国实验血液学杂志,2018,26(4):1146-1150.